ArticleJournal of cellular and molecular medicine2019

miR-200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer.

Hailin Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.